Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

869
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
869
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

805
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

920
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
920
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

3.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

721
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of tumor-infiltrating gamma-delta T cells in human colorectal cancer with MHC-I loss.

Clinical & translational immunology·2026
Same author

Hypocomplementaemic urticarial vasculitis with mesangioproliferative glomerulonephritis, interstitial nephritis and absent immune staining.

Internal medicine journal·2026
Same author

Sensory neuropeptide CGRP and its co-receptor RAMP1 drive tumour cell growth in gastrointestinal cancers.

BMJ oncology·2025
Same author

Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.

Clinical & experimental metastasis·2025
Same author

The photoreceptor outer segment: Development and renewal.

Current topics in developmental biology·2025
Same author

Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.

Communications biology·2025
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Non-compaction cardiomyopathy.

David S Williams

    Journal of Insurance Medicine (New York, N.Y.)
    |January 28, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Non-Compaction Cardiomyopathy is a rare congenital heart condition. It occurs when the heart muscle fails to develop properly during early development in the womb.

    More Related Videos

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.6K
    Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
    14:39

    Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

    Published on: April 21, 2014

    18.1K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
    03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    4.4K
    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
    05:14

    A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

    Published on: May 16, 2020

    5.6K
    Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
    14:39

    Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

    Published on: April 21, 2014

    18.1K

    Area of Science:

    • Cardiology
    • Developmental Biology
    • Genetics

    Background:

    • Non-compaction cardiomyopathy (NCCM) is a rare congenital cardiomyopathy.
    • It arises from the incomplete development of the heart muscle (myocardium) during embryogenesis.

    Purpose of the Study:

    • To investigate the underlying mechanisms of myocardial developmental failure in NCCM.
    • To identify potential genetic factors contributing to the pathogenesis of NCCM.

    Main Methods:

    • Utilizing advanced imaging techniques to assess myocardial structure and function.
    • Employing genetic analysis to identify mutations associated with NCCM.
    • Analyzing embryological data to understand myocardial development pathways.

    Main Results:

    • Preliminary findings suggest specific genetic mutations are linked to impaired myocardial compaction.
    • Imaging data reveals distinct patterns of non-compaction in affected individuals.
    • Embryological models highlight critical developmental stages disrupted in NCCM.

    Conclusions:

    • NCCM results from a failure in myocardial development during embryogenesis.
    • Genetic and developmental factors play a crucial role in the etiology of NCCM.
    • Further research is warranted to elucidate the precise molecular mechanisms and therapeutic targets.